Worse Impact of COVID-19 in Pregnant Women

Authors

  • Sarah Najm Abed Department of Pharmacology and Toxicology, College of Pharmacy, University of Kerbala, Iraq.
  • Wafaa Kadhim Jasim Department of Pharmacology and Toxicology, College of Pharmacy, University of Kerbala, Iraq
  • Amal Umran Mosa Department of Pharmacology and Toxicology, College of Pharmacy, University of Kerbala, Iraq

DOI:

https://doi.org/10.62472/kjps.v14.i23.84-91

Keywords:

COVID-19, Pregnancy, Infant

Abstract

t The COVID-19 pandemic has raised concerns about the impact of the virus on pregnant women and their unborn babies. This review aims to provide a comprehensive summary of the outcome of COVID-19 in pregnancy Studies have shown that the possibility of developing severe illness increased in pregnant women compared with non-pregnant women infected with COVID-19. They have higher rates of ICU admission, mechanical ventilation, and mortality. Additionally, the risk of preterm birth has been increased in pregnant women infected with COVID-19, with several research reporting higher rates of preterm delivery among infected pregnant women. Cesarean section delivery rates are also higher among pregnant women with COVID-19, possibly due to the need for expedited delivery in cases of severe illness or fetal distress. However, the transmission of the virus from mother to fetus is rare during pregnancy or delivery. The virus is transmitted vertically from mother to fetus, with most infants born to mothers with COVID-19 testing negative for the virus. While vertical transmission is rare, there is evidence suggesting a potential impact of COVID-19 on fetal development. Some studies have reported cases of fetal growth restriction and abnormal placental findings in pregnant women with COVID-19. However, further research is needed to fully understand the long-term consequences.

Downloads

Published

2024-05-27